HealthCare Institute of New Jersey Statement on the Prescription Drug Affordability Council
Trenton, October 11, 2024 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning the State’s recent completion of appointments